ARVN: Arvinas, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 505.16
Enterprise Value ($M) 424.66
Book Value ($M) 660.10
Book Value / Share 9.04
Price / Book 0.77
NCAV ($M) 638.70
NCAV / Share 8.75
Price / NCAV 0.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.08

Liquidity (mrq)
Quick Ratio 4.58
Current Ratio 4.58

Balance Sheet (mrq) ($M)
Current Assets 979.70
Assets 1,001.10
Liabilities 341.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 263.40
Operating Income -250.20
Net Income -198.90
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -259.30
Cash from Investing 34.70
Cash from Financing 7.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-15 13G/A EcoR1 Capital, LLC 0.00 -100.00
04-30 13G/A Vanguard Group Inc 12.15 18.72
04-17 13G/A BlackRock, Inc. 7.90 -16.52
02-14 13G/A Citadel Advisors Llc 5.10
11-14 13G/A Price T Rowe Associates Inc /md/ 5.60 0.48
11-14 13G/A Rtw Investments, Lp 4.10 -33.97

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-05 371,544 1,765,739 21.04
2025-06-04 361,755 1,377,217 26.27
2025-06-03 450,658 2,223,172 20.27
2025-06-02 817,412 3,581,705 22.82

(click for more detail)

Similar Companies
ANNX – Annexon, Inc. APLS – Apellis Pharmaceuticals, Inc.
ARQT – Arcutis Biotherapeutics, Inc. ARWR – Arrowhead Pharmaceuticals, Inc.
ASMB – Assembly Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io